FR2905380B1 - Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+ - Google Patents

Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+

Info

Publication number
FR2905380B1
FR2905380B1 FR0653567A FR0653567A FR2905380B1 FR 2905380 B1 FR2905380 B1 FR 2905380B1 FR 0653567 A FR0653567 A FR 0653567A FR 0653567 A FR0653567 A FR 0653567A FR 2905380 B1 FR2905380 B1 FR 2905380B1
Authority
FR
France
Prior art keywords
cells
dermic
monocytes
interstitial
dentritic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0653567A
Other languages
English (en)
French (fr)
Other versions
FR2905380A1 (fr
Inventor
Nicolas Bechetoille
Valerie Andre
Isabelle Orly
Eric Perrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Engelhard Lyon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0653567A priority Critical patent/FR2905380B1/fr
Application filed by Engelhard Lyon SA filed Critical Engelhard Lyon SA
Priority to EP07803152A priority patent/EP2064318A1/en
Priority to BRPI0716107-7A2A priority patent/BRPI0716107A2/pt
Priority to PCT/EP2007/059165 priority patent/WO2008028882A1/en
Priority to JP2009526123A priority patent/JP2010502175A/ja
Priority to KR1020097006847A priority patent/KR20090049620A/ko
Priority to CA002662231A priority patent/CA2662231A1/en
Publication of FR2905380A1 publication Critical patent/FR2905380A1/fr
Application granted granted Critical
Publication of FR2905380B1 publication Critical patent/FR2905380B1/fr
Priority to US12/851,592 priority patent/US20100297765A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/097—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells oral mucosa cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1121—Dendritic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1157—Monocytes, macrophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/243—Cells of the female genital tract, non-germinal ovarian cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0653567A 2006-09-04 2006-09-04 Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+ Expired - Fee Related FR2905380B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0653567A FR2905380B1 (fr) 2006-09-04 2006-09-04 Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+
BRPI0716107-7A2A BRPI0716107A2 (pt) 2006-09-04 2007-09-03 mÉtodos para preparar cÉlulas de langerhans ou cÉlulas dendrÍticas e para diferenciar monàcitos, modelo de cÉlulas, monàcitos cd14+ congelados, uso de pelo menos um modelo de cÉlula e/ou de pelo menos um modelo de tecido, e, mÉtodos para produzir um modelo de tecido, e uma pele reconstruÍda ou uma mucosa reconstruÍda
PCT/EP2007/059165 WO2008028882A1 (en) 2006-09-04 2007-09-03 A method for producing langerhans cells and/or dermal/interstitial dentritic cells from cd14+ monocytes
JP2009526123A JP2010502175A (ja) 2006-09-04 2007-09-03 Cd14+単球からランゲルハンス細胞及び/又は真皮/間質性樹状細胞を製造する方法
EP07803152A EP2064318A1 (en) 2006-09-04 2007-09-03 A method for producing langerhans cells and/or dermal/interstitial dentritic cells from cd14+ monocytes
KR1020097006847A KR20090049620A (ko) 2006-09-04 2007-09-03 Cd14+ 단구로부터 랑게르한스 세포 및/또는 진피/간질성 수지상 세포를 생성시키는 방법
CA002662231A CA2662231A1 (en) 2006-09-04 2007-09-03 A method for producing langerhans cells and/or dermal/interstitial dendritic cells from cd14+ monocytes
US12/851,592 US20100297765A1 (en) 2006-09-04 2010-08-06 Method for producing langerhans cells or interstitial dendritic cells or both from cd14+ monocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0653567A FR2905380B1 (fr) 2006-09-04 2006-09-04 Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+

Publications (2)

Publication Number Publication Date
FR2905380A1 FR2905380A1 (fr) 2008-03-07
FR2905380B1 true FR2905380B1 (fr) 2008-12-05

Family

ID=37781699

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0653567A Expired - Fee Related FR2905380B1 (fr) 2006-09-04 2006-09-04 Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+

Country Status (7)

Country Link
EP (1) EP2064318A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010502175A (cg-RX-API-DMAC7.html)
KR (1) KR20090049620A (cg-RX-API-DMAC7.html)
BR (1) BRPI0716107A2 (cg-RX-API-DMAC7.html)
CA (1) CA2662231A1 (cg-RX-API-DMAC7.html)
FR (1) FR2905380B1 (cg-RX-API-DMAC7.html)
WO (1) WO2008028882A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010225438A1 (en) * 2009-03-17 2011-10-13 The Heart Research Institute Ltd Method of cell differentiation and uses therefor in screening, diagnosis and therapy
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same
US20220025337A1 (en) * 2018-11-30 2022-01-27 Shiseido Company, Ltd. Pigmentation skin model and method for producing same, and method for evaluating factor for treating or preventing pigmentation of skin
EP3991797A4 (en) * 2019-09-17 2023-06-14 Toppan Inc. CELL STRUCTURE AND METHODS OF PRODUCTION THEREOF
FR3132146B1 (fr) * 2022-01-27 2025-10-31 Genoskin Modèle humain ex vivo destiné à l’évaluation du potentiel vaccinal d’une composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2743817B1 (fr) * 1996-01-23 1998-03-13 Oreal Equivalent de peau comprenant des cellules de langerhans
US7566568B2 (en) * 2001-04-27 2009-07-28 Istituto Superiore Di Sanita Method for generating highly active human dendritic cells from peripheral blood mononuclear cells
FR2833271B1 (fr) * 2001-12-10 2004-09-17 Coletica Production de cellules dendritiques in vitro a partir de monocytes cd14+, pour notamment la realisation de modeles cellulaires et/ou tissulaires en suspension, en monocouches et tridimentionnels; utilisation de ces modeles
WO2005007839A1 (ja) * 2003-07-22 2005-01-27 Kirin Beer Kabushiki Kaisha ノッチリガンドDelta-1、GM-CSF、TGF-βを用いたヒト末梢血単核球であるCD14陽性細胞からのランゲルハンス細胞の調製方法

Also Published As

Publication number Publication date
EP2064318A1 (en) 2009-06-03
JP2010502175A (ja) 2010-01-28
CA2662231A1 (en) 2008-03-13
FR2905380A1 (fr) 2008-03-07
WO2008028882A1 (en) 2008-03-13
BRPI0716107A2 (pt) 2013-09-24
KR20090049620A (ko) 2009-05-18

Similar Documents

Publication Publication Date Title
EP2033981A4 (en) POLYCARBONATE COPOLYMER AND MANUFACTURING METHOD THEREFOR
EP1921734A4 (en) PROCESS FOR PRODUCING A ROTOR AND ROTOR
EP2100967A4 (en) METHOD FOR PRODUCING LACTO-N-BIOSE I OR GALACTO-N-BIOSE
IL228362A (en) A method for preparing sugars by biological mass processing
EP2264079A4 (en) COPOLYMER AND METHOD FOR ITS MANUFACTURE
EP2308511A4 (en) TABLET QUICKLY CRUMPING IN THE MOUTH VALVE AND MANUFACTURING METHOD THEREFOR
EP2010104A4 (en) Calcium phosphate-polymer composition and method
EP1852454A4 (en) POLYROTAXAN AND POLYMER-CONTAINED MATERIAL AND METHOD OF MANUFACTURING THEREOF
EP2318501A4 (en) POLYMERIC COMPOSITION AND MANUFACTURING METHOD THEREFOR
EP2239043A4 (en) SEPARATE MEMBRANE ELEMENTS, SEPARATE MEMBRANE MODULE AND METHOD FOR PRODUCING A SEPARATE MEMBRANE ELEMENT
EP2495311A4 (en) METHOD FOR THE PRODUCTION OF MESENCHYMAL STEM CELLS FROM PLURIPOTENTIAL HUMAN STEM CELLS AND MESENCHYMM STEM CELLS MADE IN THIS PROCEDURE
EP2484701A4 (en) METHOD FOR PRODUCING A MODIFIED CONJUGATED DIENPOLYMER, MODIFIED CONJUGATE DIENPOLYMER, AND COMPOSITION COMPRISING THE MODIFIED CONJUGATED DIENPOLYMER
BRPI0916498A2 (pt) Método de produção de biomassa enriquecida com carboidratos e método de fragmentação simultânea e extração seletiva de lignina
EP2075265A4 (en) BETA-PINEN POLYMER AND METHOD OF MANUFACTURING THEREOF
EP2205336A4 (en) System and method for producing dry formulations
EP2011860A4 (en) BACTERIUM WITH ABILITY TO PRODUCE A PURINE SUBSTANCE AND PROCESS FOR PRODUCING THE PURIN SUBSTANCE
EP2130909A4 (en) METHOD FOR THE MANUFACTURE OF TOOTH AND THEREFORE MANUFACTURED TOOTH
EP2003194A4 (en) BIOKOMPATIBLE TRANSPARENT FILM, METHOD FOR THE MANUFACTURE THEREOF AND CELL FOIL
EP2065408A4 (en) HYBRID BRANCHED POLYMER AND METHOD OF MANUFACTURING THEREOF
EP2096647A4 (en) PROCESS FOR PREPARING A POLYELECTROLYTMEMBRANE AND POLYELECTROLYTMEMBRANE
EP2133136A4 (en) DISCONNECTING MEMBRANE AND MANUFACTURING METHOD THEREFOR
EP2161073A4 (en) SEPARATE MEMBRANE PLEXLEX AND METHOD FOR PRODUCING A SEPARATED MEMBRANE PLEXE
EP2226121A4 (en) METHOD FOR PRODUCING AN OXID CATALYST
EP2437332A4 (en) POSITIVE ELECTRODE AND METHOD OF MANUFACTURE THEREOF
EP2070964A4 (en) METHOD FOR PRODUCING HYDROGENATED POLYMERS AND HYDROGENATED POLYMERS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20180531